Matrine also increased the mRNA levels of nuclear factor erythroid 2-like 2 (Nrf2) and heme oxygenase-1 (HO-1), two key proteins that maintain cellular redox balance, in hyperglycemia-treated cardiomyocytes (Figures 1E–I). This evidence concerns the gene NFE2L2 and Hyperglycemia.